Skip to content
Home/Companies/Biotech/Arriva Pharmaceuticals

Arriva Pharmaceuticals

Biotech·US·Active·18yr hold
Entry
2008
Hold
18yr
Status
Active

Who owns Arriva Pharmaceuticals?

Arriva Pharmaceuticals is currently owned by Nordic Biotech Advisors through Nordic Biotech II K/S (2006 vintage), since 2008.

Hand-verified · updated 2026-08-18

Nordic Biotech Advisors
Investor
Nordic Biotech Advisors
Nordic Biotech II K/S · 2006 · Life Sciences VC

Key facts

HQUnited States
SectorBiotech
StatusActive

More Nordic Biotech Advisors portfolio companies

From the same investor, across funds.

Forward Pharma
Exited 2014
BiotechDenmark· 2006
Curalogic
Exited 2006
BiotechDenmark· 2004
Gastrotech Pharma
Active
BiotechDenmark· 2003
Osteologix
Exited 2006
BiotechDenmark· 2003
LifeCycle Pharma
Exited 2006
PharmaDenmark· 2002

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track Arriva Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Arriva Pharmaceuticals?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Arriva Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue